首页> 外文期刊>Journal of diabetes research. >Urinary Excretion of Kidney Aquaporins as Possible Diagnostic Biomarker of Diabetic Nephropathy
【24h】

Urinary Excretion of Kidney Aquaporins as Possible Diagnostic Biomarker of Diabetic Nephropathy

机译:肾脏水通道蛋白的尿排泄可能是糖尿病肾病的诊断生物标志物

获取原文
           

摘要

Diabetic nephropathy (DN) is a microangiopathic complication of diabetes mellitus (DM) affecting one-third of diabetic patients. The large variability in the clinical presentation of renal involvement in patients with DM makes kidney biopsy a prerequisite for a correct diagnosis. However, renal biopsy is an invasive procedure associated with risk of major complications. Numerous studies aimed to identify a noninvasive biomarker of DN but, so far, none of these is considered to be sufficiently specific and sensitive. Water channel aquaporins (AQPs), expressed at the plasma membrane of epithelial tubular cells, are often dysregulated during DN. In this work, we analyzed the urine excretion of AQP5 and AQP2 (uAQP5 and uAQP2), via exosomes, in 35 diabetic patients 12 normoalbuminuric with normal renal function (DM), 11 with proteinuric nondiabetic nephropathy (NDN), and 12 with histological diagnosis and classification of DN. ELISA and WB analysis independently showed that uAQP5 was significantly increased in DN patients. Interestingly, linear regression analysis showed a positive correlation between uAQP5 and the histological class of DN. The same analysis, focusing on uAQP2, showed comparable results. Taken together, these data suggest a possible use of AQP5 and AQP2 as novel noninvasive biomarkers to help in classifying the clinical stage of DN.
机译:糖尿病肾病(DN)是一种糖尿病(DM)的微血管病性并发症,影响了三分之一的糖尿病患者。 DM患者肾脏受累临床表现的巨大差异使肾脏活检成为正确诊断的先决条件。然而,肾脏活检是一种侵入性手术,具有重大并发症的风险。众多研究旨在鉴定DN的非侵入性生物标志物,但到目前为止,这些研究都没有被认为具有足够的特异性和敏感性。在上皮肾小管细胞质膜上表达的水通道水通道蛋白(AQP)在DN期间常常失调。在这项工作中,我们通过外泌体分析了35例糖尿病患者的AQP5和AQP2(uAQP5和uAQP2)的尿排泄情况,其中12例肾功能正常的正常白蛋白尿,11例蛋白尿性非糖尿病肾病(NDN)和12例组织学诊断DN的分类。 ELISA和WB分析独立显示DN患者中uAQP5显着增加。有趣的是,线性回归分析显示uAQP5与DN的组织学类别呈正相关。针对uAQP2的相同分析显示了可比的结果。综上所述,这些数据表明可能将AQP5和AQP2用作新型无创生物标志物,以帮助对DN的临床阶段进行分类。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号